Tristel
Research Tristel (TSTL) on Bullrun: market cap GBX 18.72B, P/E 24.4, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTSTL
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyGBX
- Market capGBX 18.72B
- P/E24.4
- Dividend yield3.7%
- Financial periodFY2025
- RevenueGBP 46.46M
- Revenue growth10.8%
- Net incomeGBP 6.64M
- Free cash flowGBP 8.33M
- Gross margin80.6%
Valuation Snapshot
latest market cap is GBX 18.72B; P/E is 24.4; dividend yield is 3.7%.
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.
Frequently asked questions
What is Tristel's market cap?
Tristel's market capitalization is GBX 18.72B.
What is Tristel's P/E ratio?
Tristel's price-to-earnings (P/E) ratio is 24.4.
Does Tristel pay a dividend?
Tristel has a dividend yield of 3.7%.
What does Tristel do?
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.